HALO - Halozyme Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HALO is currently covered by 9 analysts with an average price target of $78.35. This is a potential upside of -$32.05 (-29.03%) from yesterday's end of day stock price of $110.4.

Halozyme Therapeutics's activity chart (see below) currently has 310 price targets and 233 ratings on display. The stock rating distribution of HALO is 70.83% BUY, 8.33% SELL and 20.83% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 84.91% with an average time for these price targets to be met of 237.79 days.

Highest price target for HALO is $115, Lowest price target is $56, average price target is $78.35.

Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 02-Sep-2026. First documented stock forecast 12-Jun-2014.

Best performing analysts who are covering HALO - Halozyme Therapeutics:

Jason Butler Jim Birchenough Mitchell Kapoor Brendan Smith Vikram Purohit

Currently out of the existing stock ratings of HALO, 17 are a BUY (70.83%), 2 are a SELL (8.33%), 5 are a HOLD (20.83%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Jul-2023

$115

$1.1 (0.97%)

$115

29 days ago
(02-Sep-2026)

46/46 (100%)

$5.34 (4.87%)

176

Buy Since 29-Feb-2024

$105

$-8.9 (-7.81%)

$90

1 months 24 days ago
(07-Aug-2026)

9/9 (100%)

$1.88 (1.82%)

187

Buy Since 27-Nov-2018

$93

$-20.9 (-18.35%)

$92

1 months 24 days ago
(07-Aug-2026)

16/17 (94.12%)

$-10.12 (-9.81%)

395

Hold Since 13-Jan-2025

$95

$-18.9 (-16.59%)

$75

1 months 24 days ago
(07-Aug-2026)

9/10 (90%)

$-8.12 (-7.87%)

302

Buy Since 18-Aug-2025

$93

$18.04 (24.07%)

$79

4 months 19 days ago
(12-May-2026)

11/12 (91.67%)

$22.07 (31.12%)

270

Show more analysts

Please expand the browser size to see the chart

What is HALO (Halozyme Therapeutics) average time for price targets to be met?

On average it took 238 days for the stock forecasts to be reached, with an average price target met ratio of 84.91%.

Which analyst most recently updated their price target on HALO (Halozyme Therapeutics)?

Mitchell Kapoor

Which analyst has the most public recommendations on HALO (Halozyme Therapeutics)?

Mitchell Kapoor has 22 price targets and 24 ratings on HALO

Which analyst is the currently most bullish on HALO (Halozyme Therapeutics)?

Vikram Purohit with the highest potential upside of $18.04

Which analyst is the currently most reserved on HALO (Halozyme Therapeutics)?

Eun Yang with the lowest potential downside of -$100.9
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?